Yau, Jade C.
Yu, Shu Min
Panenka, William J.
Pearce, Hadley
Gicas, Kristina M.
Procyshyn, Ric M.
MacCallum, Caroline
Honer, William G.
Barr, Alasdair M.
Funding for this research was provided by:
Mitacs (NA)
Article History
Received: 25 March 2019
Accepted: 15 October 2019
First Online: 1 November 2019
Ethics approval and consent to participate
: All subjects provided written informed consent. The study was approved by the Behavioural Research Ethics Board of the University of British Columbia (protocol H16–01830).
: Not applicable.
: WJP is the founder and Chief Executive Officer of Translational Life Sciences, an early stage science company focused on cannabinoid therapeutics. He is also on the scientific advisory board of Medipure Pharmaceuticals and Vitality Biopharma, and in the past has been on the board of directors for Abbatis bioceuticals and on the advisory board of Vinergy Resources.RMP has been a member of the following scientific advisory board in the past 3 years: Janssen, Lundbeck, and Otsuka; a member of the following speaker’s bureaus in the past 3 years: Janssen, Lundbeck, and Otsuka; and received grants from the Canadian Institutes of Health Research.CM is the Medical Director of Greenleaf Medical Clinic and Translational Life Sciences. She is on the Board of Directors for The Green Organic Dutchman and is on the Medical Advisory Board for Emerald Health Therapeutics. She has provided medical consultation and/or received support for industry sponsored continuing medical education from; Canopy/Spectrum, Strainprint, Scientus Pharma, Aurora, MedReleaf, Shoppers Drug Mart, and MD Briefcase. Previously she has also worked with Vitality Biopharma, True Leaf, Resolve Digital Health, Doja and Compass Cannabis Clinics.WGH has received consulting fees or sat on paid advisory boards for: the Canadian Agency for Drugs and Technology in Health, AlphaSights, In Silico, Otsuka, Lundbeck, Translational Life Sciences and Newron.AMB has been a scientific advisor to Emerald Health Therapeutics, Cannevert Therapeutics, Global Cannabis Applications Corp, Entourage Biosciences, Medipure Pharmaceuticals and Vitality Biopharma.All other authors declare that they have no competing interest.